Do analysts recommend CRVL or TEM?

Tempus AI has a consensus price target of $69.63, indicating a potential downside of 16.64%. Given Tempus AI's stronger consensus rating and higher probable upside, analysts plainly believe Tempus AI is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CorVel 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Tempus AI 2 Sell rating(s) 9 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.41

Which has preferable earnings and valuation, CRVL or TEM?

CorVel has higher earnings, but lower revenue than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CorVel $958.53M 3.99 $110.34M $2.25 33.32 Tempus AI $1.27B 11.85 -$245.03M -$1.44 N/A

Is CRVL or TEM more profitable?

CorVel has a net margin of 11.72% compared to Tempus AI's net margin of -17.77%. CorVel's return on equity of 29.92% beat Tempus AI's return on equity. Company Net Margins Return on Equity Return on Assets CorVel 11.72% 29.92% 17.82% Tempus AI -17.77% -50.28% -10.33%

Does the media favor CRVL or TEM?

In the previous week, Tempus AI had 13 more articles in the media than CorVel. MarketBeat recorded 18 mentions for Tempus AI and 5 mentions for CorVel. CorVel's average media sentiment score of 1.14 beat Tempus AI's score of 0.75 indicating that CorVel is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CorVel 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tempus AI 9 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer FMS or CRVL?

Fresenius Medical Care AG & Co. KGaA currently has a consensus target price of $23.68, suggesting a potential upside of 5.15%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fresenius Medical Care AG & Co. KGaA 5 Sell rating(s) 7 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.58 CorVel 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media favor FMS or CRVL?

In the previous week, CorVel had 1 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 5 mentions for CorVel and 4 mentions for Fresenius Medical Care AG & Co. KGaA. CorVel's average media sentiment score of 1.14 beat Fresenius Medical Care AG & Co. KGaA's score of 0.63 indicating that CorVel is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fresenius Medical Care AG & Co. KGaA 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CorVel 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate CRVL or DVA?

DaVita has a consensus price target of $233.43, suggesting a potential upside of 31.22%. Given DaVita's stronger consensus rating and higher possible upside, analysts plainly believe DaVita is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CorVel 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 DaVita 0 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.43

Which has preferable valuation & earnings, CRVL or DVA?

DaVita has higher revenue and earnings than CorVel. DaVita is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CorVel $958.53M 3.99 $110.34M $2.25 33.32 DaVita $14.01B 0.81 $746.80M $12.22 14.56

Is CRVL or DVA more profitable?

CorVel has a net margin of 11.72% compared to DaVita's net margin of 6.05%. CorVel's return on equity of 29.92% beat DaVita's return on equity. Company Net Margins Return on Equity Return on Assets CorVel 11.72% 29.92% 17.82% DaVita 6.05% -217.63% 5.07%

Does the media refer more to CRVL or DVA?

In the previous week, CorVel had 1 more articles in the media than DaVita. MarketBeat recorded 5 mentions for CorVel and 4 mentions for DaVita. CorVel's average media sentiment score of 1.14 beat DaVita's score of 0.00 indicating that CorVel is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CorVel 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DaVita 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor BTSG or CRVL?

In the previous week, BrightSpring Health Services had 1 more articles in the media than CorVel. MarketBeat recorded 6 mentions for BrightSpring Health Services and 5 mentions for CorVel. CorVel's average media sentiment score of 1.14 beat BrightSpring Health Services' score of 0.99 indicating that CorVel is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BrightSpring Health Services 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CorVel 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate CRVL or HNGE?

Hinge Health has a consensus price target of $105.33, suggesting a potential upside of 7.60%. Given Hinge Health's stronger consensus rating and higher probable upside, analysts clearly believe Hinge Health is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CorVel 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Hinge Health 0 Sell rating(s) 3 Hold rating(s) 15 Buy rating(s) 1 Strong Buy rating(s) 2.89

Which has stronger earnings & valuation, CRVL or HNGE?

CorVel has higher revenue and earnings than Hinge Health. CorVel is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CorVel $958.53M 3.99 $110.34M $2.25 33.32 Hinge Health $720.06M 10.97 -$528.26M $1.28 76.48

Is CRVL or HNGE more profitable?

Hinge Health has a net margin of 15.15% compared to CorVel's net margin of 11.72%. Hinge Health's return on equity of 51.60% beat CorVel's return on equity. Company Net Margins Return on Equity Return on Assets CorVel 11.72% 29.92% 17.82% Hinge Health 15.15% 51.60% 14.16%

Does the media refer more to CRVL or HNGE?

In the previous week, Hinge Health had 9 more articles in the media than CorVel. MarketBeat recorded 14 mentions for Hinge Health and 5 mentions for CorVel. CorVel's average media sentiment score of 1.14 beat Hinge Health's score of 0.48 indicating that CorVel is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CorVel 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hinge Health 3 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

CorVel (CRVL) Competitors

$74.97 +0.50 (+0.68%)

As of 01:39 PM Eastern

Compare

CRVL vs. TEM, FMS, DVA, BTSG, and HNGE

Should you buy CorVel stock or one of its competitors? CorVel's main competitors and comparable companies include Tempus AI (TEM), Fresenius Medical Care AG & Co. KGaA (FMS), DaVita (DVA), BrightSpring Health Services (BTSG), and Hinge Health (HNGE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does CorVel compare to Tempus AI?

CorVel (NASDAQ:CRVL) and Tempus AI (NASDAQ:TEM) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, earnings, valuation, media sentiment, profitability, analyst recommendations and dividends.

Tempus AI has a consensus price target of $69.63, indicating a potential downside of 16.64%. Given Tempus AI's stronger consensus rating and higher probable upside, analysts plainly believe Tempus AI is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CorVel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Tempus AI	2 Sell rating(s)	9 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.41

CorVel has higher earnings, but lower revenue than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CorVel	$958.53M	3.99	$110.34M	$2.25	33.32
Tempus AI	$1.27B	11.85	-$245.03M	-$1.44	N/A

In the previous week, Tempus AI had 13 more articles in the media than CorVel. MarketBeat recorded 18 mentions for Tempus AI and 5 mentions for CorVel. CorVel's average media sentiment score of 1.14 beat Tempus AI's score of 0.75 indicating that CorVel is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CorVel	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tempus AI	9 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

51.4% of CorVel shares are held by institutional investors. Comparatively, 24.2% of Tempus AI shares are held by institutional investors. 39.7% of CorVel shares are held by insiders. Comparatively, 24.3% of Tempus AI shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

CorVel has a net margin of 11.72% compared to Tempus AI's net margin of -17.77%. CorVel's return on equity of 29.92% beat Tempus AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CorVel	11.72%	29.92%	17.82%
Tempus AI	-17.77%	-50.28%	-10.33%

CorVel has a beta of 0.97, meaning that its share price is 3% less volatile than the broader market. Comparatively, Tempus AI has a beta of 3.72, meaning that its share price is 272% more volatile than the broader market.

Summary

CorVel beats Tempus AI on 9 of the 16 factors compared between the two stocks.

How does CorVel compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and CorVel (NASDAQ:CRVL) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, risk, dividends, valuation and earnings.

In the previous week, CorVel had 1 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 5 mentions for CorVel and 4 mentions for Fresenius Medical Care AG & Co. KGaA. CorVel's average media sentiment score of 1.14 beat Fresenius Medical Care AG & Co. KGaA's score of 0.63 indicating that CorVel is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care AG & Co. KGaA	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CorVel	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. Comparatively, 51.4% of CorVel shares are owned by institutional investors. 39.7% of CorVel shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

CorVel has a net margin of 11.72% compared to Fresenius Medical Care AG & Co. KGaA's net margin of 4.83%. CorVel's return on equity of 29.92% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%
CorVel	11.72%	29.92%	17.82%

Fresenius Medical Care AG & Co. KGaA currently has a consensus target price of $23.68, suggesting a potential upside of 5.15%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.58
CorVel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Fresenius Medical Care AG & Co. KGaA has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market. Comparatively, CorVel has a beta of 0.97, indicating that its stock price is 3% less volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than CorVel. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.93	11.67
CorVel	$958.53M	3.99	$110.34M	$2.25	33.32

Summary

CorVel beats Fresenius Medical Care AG & Co. KGaA on 12 of the 15 factors compared between the two stocks.

How does CorVel compare to DaVita?

CorVel (NASDAQ:CRVL) and DaVita (NYSE:DVA) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, dividends, analyst recommendations, valuation, media sentiment, profitability and earnings.

DaVita has a consensus price target of $233.43, suggesting a potential upside of 31.22%. Given DaVita's stronger consensus rating and higher possible upside, analysts plainly believe DaVita is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CorVel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
DaVita	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.43

In the previous week, CorVel had 1 more articles in the media than DaVita. MarketBeat recorded 5 mentions for CorVel and 4 mentions for DaVita. CorVel's average media sentiment score of 1.14 beat DaVita's score of 0.00 indicating that CorVel is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CorVel	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DaVita	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

51.4% of CorVel shares are held by institutional investors. Comparatively, 90.1% of DaVita shares are held by institutional investors. 39.7% of CorVel shares are held by insiders. Comparatively, 1.9% of DaVita shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

DaVita has higher revenue and earnings than CorVel. DaVita is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CorVel	$958.53M	3.99	$110.34M	$2.25	33.32
DaVita	$14.01B	0.81	$746.80M	$12.22	14.56

CorVel has a net margin of 11.72% compared to DaVita's net margin of 6.05%. CorVel's return on equity of 29.92% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CorVel	11.72%	29.92%	17.82%
DaVita	6.05%	-217.63%	5.07%

CorVel has a beta of 0.97, suggesting that its share price is 3% less volatile than the broader market. Comparatively, DaVita has a beta of 0.83, suggesting that its share price is 17% less volatile than the broader market.

Summary

CorVel beats DaVita on 9 of the 16 factors compared between the two stocks.

How does CorVel compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and CorVel (NASDAQ:CRVL) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, dividends, earnings, institutional ownership and profitability.

BrightSpring Health Services has a beta of 1.84, suggesting that its stock price is 84% more volatile than the broader market. Comparatively, CorVel has a beta of 0.97, suggesting that its stock price is 3% less volatile than the broader market.

CorVel has a net margin of 11.72% compared to BrightSpring Health Services' net margin of 2.55%. CorVel's return on equity of 29.92% beat BrightSpring Health Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BrightSpring Health Services	2.55%	16.73%	5.24%
CorVel	11.72%	29.92%	17.82%

BrightSpring Health Services has higher revenue and earnings than CorVel. CorVel is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrightSpring Health Services	$14.37B	0.78	$190.67M	$1.66	34.03
CorVel	$958.53M	3.99	$110.34M	$2.25	33.32

BrightSpring Health Services currently has a consensus price target of $70.71, suggesting a potential upside of 25.17%. Given BrightSpring Health Services' stronger consensus rating and higher possible upside, equities analysts plainly believe BrightSpring Health Services is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	3.10
CorVel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

51.4% of CorVel shares are held by institutional investors. 2.8% of BrightSpring Health Services shares are held by insiders. Comparatively, 39.7% of CorVel shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, BrightSpring Health Services had 1 more articles in the media than CorVel. MarketBeat recorded 6 mentions for BrightSpring Health Services and 5 mentions for CorVel. CorVel's average media sentiment score of 1.14 beat BrightSpring Health Services' score of 0.99 indicating that CorVel is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BrightSpring Health Services	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CorVel	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

BrightSpring Health Services beats CorVel on 9 of the 17 factors compared between the two stocks.

How does CorVel compare to Hinge Health?

CorVel (NASDAQ:CRVL) and Hinge Health (NYSE:HNGE) are both mid-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, media sentiment, valuation and earnings.

In the previous week, Hinge Health had 9 more articles in the media than CorVel. MarketBeat recorded 14 mentions for Hinge Health and 5 mentions for CorVel. CorVel's average media sentiment score of 1.14 beat Hinge Health's score of 0.48 indicating that CorVel is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CorVel	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hinge Health	3 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

CorVel has a beta of 0.97, indicating that its stock price is 3% less volatile than the broader market. Comparatively, Hinge Health has a beta of 1.38, indicating that its stock price is 38% more volatile than the broader market.

CorVel has higher revenue and earnings than Hinge Health. CorVel is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CorVel	$958.53M	3.99	$110.34M	$2.25	33.32
Hinge Health	$720.06M	10.97	-$528.26M	$1.28	76.48

51.4% of CorVel shares are owned by institutional investors. 39.7% of CorVel shares are owned by company insiders. Comparatively, 18.9% of Hinge Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Hinge Health has a net margin of 15.15% compared to CorVel's net margin of 11.72%. Hinge Health's return on equity of 51.60% beat CorVel's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CorVel	11.72%	29.92%	17.82%
Hinge Health	15.15%	51.60%	14.16%

Hinge Health has a consensus price target of $105.33, suggesting a potential upside of 7.60%. Given Hinge Health's stronger consensus rating and higher probable upside, analysts clearly believe Hinge Health is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CorVel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Hinge Health	0 Sell rating(s)	3 Hold rating(s)	15 Buy rating(s)	1 Strong Buy rating(s)	2.89

Summary

Hinge Health beats CorVel on 10 of the 17 factors compared between the two stocks.

Get CorVel News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRVL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CRVL vs. The Competition

Export

Metric	CorVel	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$3.82B	$9.69B	$7.26B	$13.17B
Dividend Yield	N/A	2.59%	2.52%	14.19%
P/E Ratio	33.25	34.74	274.41	25.76
Price / Sales	3.99	5.53	659.61	91.46
Price / Cash	26.58	121.33	80.06	52.35
Price / Book	9.72	5.19	10.43	6.35
Net Income	$110.34M	$315.68M	$3.50B	$360.42M
7 Day Performance	2.28%	-1.75%	-1.17%	-1.50%
1 Month Performance	8.28%	-1.65%	-4.03%	-4.03%
1 Year Performance	-3.16%	9.75%	12.93%	3.96%

CorVel Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CRVL CorVel	1.5953 of 5 stars	$74.97 +0.7%	N/A	-3.6%	$3.82B	$958.53M	33.25	5,239	Positive News
TEM Tempus AI	1.6358 of 5 stars	$77.84 -0.2%	$69.63 -10.5%	+5.1%	$14.05B	$1.27B	N/A	3,800	Analyst Downgrade
FMS Fresenius Medical Care AG & Co. KGaA	3.0251 of 5 stars	$22.65 +1.9%	$23.57 +4.1%	-13.6%	$12.15B	$22.20B	11.72	1,488	News Coverage Analyst Downgrade
DVA DaVita	4.542 of 5 stars	$184.59 +1.2%	$233.43 +26.5%	+33.9%	$11.76B	$13.64B	15.08	78,000
BTSG BrightSpring Health Services	4.7285 of 5 stars	$56.43 +1.0%	$70.71 +25.3%	+98.0%	$11.19B	$12.91B	34.06	23,500

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CRVL) was last updated on 9/30/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CorVel (CRVL) Competitors